Loading clinical trials...
Loading clinical trials...
A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Refractory Cancers
Conditions
Interventions
PDTF-Guided Personalized Treatment
PDTF-Guided Personalized Treatment
Locations
1
China
Qilu Hospital of Shandong Univertisy
Jinan, Shandong, China
Start Date
March 1, 2024
Primary Completion Date
December 30, 2027
Completion Date
December 30, 2027
Last Updated
December 4, 2025
NCT07477743
NCT07218874
NCT04389281
NCT07309770
NCT07299747
NCT07128914
Lead Sponsor
Qilu Hospital of Shandong University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions